A trio of world-leading neuroscientists has joined the University of Sydney’s Brain and Mind Centre to “progress research-led treatments for dementia and other neurodegenerative diseases affecting human memory and thinking”. Professor Glenda Halliday, Professor John Hodges and Professor Olivier Piguet bring a significant team of researchers, PhD students and professional staff. Professor Halliday is a specialist in the pathology of neurodegenerative diseases, a senior principal research fellow of the National Health and Medical Research Council, a past president of the Australian Neuroscience Society and part of the Academy of the National Health and Medical Research Council of Australia. Professor Hodges leads a multidisciplinary research group focused on aspects of frontotemporal dementia. He has authored 500 papers on aspects of memory, language and dementia, in addition to six books. Professor Hodges is a former lecturer in behaviour neurology at the University of Cambridge. Professor Piguet is an international expert on cognitive and clinical changes in pathological brain ageing who has published over 150 peer-reviewed journal articles on this topic. His research has recently focused on the biological correlates of deficits in social cognition and memory in frontotemporal dementia and related conditions. “A major reason for joining the University of Sydney is that we are at a critical stage of translating many of our research projects into neurological research clinics with the aims of testing new diagnostic methods and preclinical treatment evaluations,” Professor Halliday said.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.